MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway

MTA1 is a metastasis-associated protein, which is essential to epithelial-to-mesenchymal transition (EMT). However, information concerning its up- and downstream regulation is rare. We investigated its upstream regulation and downstream effector in human hepatocellular carcinoma (HCC). In total, 94 paired HCC and adjacent tissue samples were involved in the study, and the results indicated that decreased miR-30e levels were associated with increased MTA1 levels in human HCC. miR-30e exerted its regulation of MTA1 transcription by binding to its 3′-untranslated region, and was negatively associated with EMT. Furthermore, significantly higher expression of MTA1 was associated with overexpression of v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ErbB2) in human HCC, and MTA1 can promote transcription of ErbB2 by binding with histone deacetylase 2 (HDAC2) and acting as a promoter. The EMT promotion effect caused by MTA1 largely depended on ErbB2, and reducing the activity of ErbB2 can significantly attenuate EMT promotion by causing overexpression of MTA1 both in vitro and in vivo. In general, downregulation of miR-30e can increase levels of MTA1 in human HCC, and furthermore promote cell invasion and metastasis by promoting ErbB2.

[1]  Xu Zhang,et al.  MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities , 2014, Cancer and Metastasis Reviews.

[2]  K. Chayama,et al.  MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma , 2016, International journal of molecular sciences.

[3]  Clotilde Théry,et al.  Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.

[4]  Cheng Huang,et al.  Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. , 2014, Cancer letters.

[5]  Y. Shin,et al.  Hepatitis B virus X protein induces the expression of MTA1 and HDAC1, which enhances hypoxia signaling in hepatocellular carcinoma cells , 2008, Oncogene.

[6]  K. Sugimachi,et al.  The role of MTA1 gene expression in human hepatocellular carcinoma. , 2003, Oncology reports.

[7]  S. Chakraborty,et al.  Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma. , 2016, The American journal of pathology.

[8]  Xuehao Wang,et al.  Inhibition of MTA1 by ERα contributes to protection hepatocellular carcinoma from tumor proliferation and metastasis , 2015, Journal of Experimental & Clinical Cancer Research.

[9]  B. Bao,et al.  Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells , 2012, Molecular Cancer Therapeutics.

[10]  G. Nicolson,et al.  A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. , 1994, The Journal of biological chemistry.

[11]  Yaping Tian,et al.  miRNA for diagnosis and clinical implications of human hepatocellular carcinoma , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[12]  Kamini Singh,et al.  MTA family of coregulators in nuclear receptor biology and pathology , 2007, Nuclear receptor signaling.

[13]  M. Caraglia,et al.  HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT , 2011, Journal of cellular physiology.

[14]  Da-Qiang Li,et al.  Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer. , 2012, Cancer research.

[15]  Z. Zou,et al.  Immunotherapeutic interventions in chronic hepatitis B virus infection: a review. , 2014, Journal of immunological methods.

[16]  Parul Gupta,et al.  HER2 mediated de novo production of TGFβ leads to SNAIL driven epithelial‐to‐mesenchymal transition and metastasis of breast cancer , 2014, Molecular oncology.

[17]  X. Bian,et al.  Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial–mesenchymaltransition , 2011, Gut.

[18]  B. Gui,et al.  Role of MTA1 in cancer progression and metastasis , 2014, Cancer and Metastasis Reviews.

[19]  Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system , 2014, Cancer and Metastasis Reviews.

[20]  Bin Liu,et al.  Down-Regulation of MiR-30c Promotes the Invasion of Non-Small Cell Lung Cancer by Targeting MTA1 , 2013, Cellular Physiology and Biochemistry.

[21]  S. McMahon,et al.  Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  P. Isakson,et al.  c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation. , 2005, International journal of oncology.

[23]  P. Hotez,et al.  Inflammatory response to liver fluke Opisthorchis viverrini in mice depends on host master coregulator MTA1, a marker for parasite‐induced cholangiocarcinoma in humans , 2011, Hepatology.

[24]  C. Melief,et al.  Vaccines for established cancer: overcoming the challenges posed by immune evasion , 2016, Nature Reviews Cancer.

[25]  E. Yu,et al.  Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma , 2008, Hepatology.

[26]  L. Mishra,et al.  TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells , 2011, Oncogene.